Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.

Latest From David Ridley

P&G JV Clearblue Empowers British Women Trying To Conceive

Procter & Gamble joint venture Clearblue has launched a UK PR campaign aimed at de-stigmatizing the conception pre-pregnancy phase by putting control and confidence back in women’s hands.

Health OTC Drugs

David Vs Goliath – Flarin’s Macmillen On Slugging It Out With The Heavyweights

HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.

Health OTC Drugs

Asia’s OTC Market Stunted By Regulatory Disharmony

HBW Insight Exclusive: A lack of regulatory harmonization, especially with regards to Rx-to-OTC switch, is holding the Asia-Pacific OTC market back, according to APSMI secretary general, Toshi Tominaga.

Health OTC Drugs

German OTC Marketing Round-Up: Allergy Launches From Novartis, Hevert, Dermapharm And Bencard

OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard. 

Health OTC Drugs

Tapping The UK Probiotics Trend: Sanofi Launches Buscobiota, Two Nootropics From Protexin

Sanofi enters the probiotics space with Buscobiota in the UK, and British probiotics specialist Protexin adds two brain health supplements to its Bio-Kult range.

Wellness Dietary Supplements

CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm

Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend. 

International Wellness
See All
UsernamePublicRestriction

Register